Skip to main content
Medical information Clinical review pending

Infection Testing

Babesia Microti Antibodies IgG IgM Test

Detects antibodies for Babesia microti, the parasite causing Babesiosis, a tick-borne illness. This test helps identify recent or past infections.

General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.

Review status: No completed medical review is recorded for this page.

Ask a question
Counselor guidance included Confidential handling Kenya-wide coordination

At a glance

Plan your test

Sample
2 mL (0.5 mL minimum) serum collected in an SST tube.
Results
Confirm with the laboratory before booking.
Preparation
No special preparation is required for this test.
Test priceKSh 40,000

Payment: M-Pesa and card options can be confirmed during booking.

Insurance & government schemes

Is this test covered for you?

We help you verify whether the Babesia Microti Antibodies IgG IgM Test test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.

Talk to a claims advisor

Providers & schemes we can help you check

Government & public schemes

SHIF — Social Health Insurance Fund Linda Mama EduAfya NHIF (legacy cards)

Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.

Private insurers & employer schemes

Jubilee Health AAR APA Britam CIC Madison Resolution Pioneer Minet Old Mutual GA Life Heritage + other licensed insurers

Names shown for identification only — listing does not imply partnership or guarantee of coverage.

Have these ready when we check

  • Insurer or scheme name & policy / member number
  • A clinician's request / prescription for the test
  • Pre-authorisation letter, if your plan requires one

Free coverage check

Ask us to verify your cover

Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.

+254

Used only to process your coverage check — see our Privacy Policy. Verification support is free and does not guarantee your provider will pay.

01

Start with fit

Is this the right test for you?

The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.

  • ✓Suspected exposure to ticks in endemic areas.
  • ✓Symptoms suggestive of Babesiosis (fever, chills, sweats, headache, muscle aches).
  • ✓Monitoring for infection in high-risk individuals (e.g., immunocompromised).
  • ✓Evaluating potential tick-borne illness after a tick bite.
02

In plain language

What this test helps you understand

This test helps diagnose Babesiosis, a tick-borne parasitic infection, by detecting antibodies against the Babesia microti parasite. It can differentiate between recent (IgM) and past/ongoing (IgG) infections, aiding in clinical management.
The Babesia Microti Antibodies IgG IgM Test is a diagnostic tool used to detect antibodies against the Babesia microti parasite, which causes Babesiosis. This is a tick-borne disease that can cause significant health issues if not diagnosed early. Understanding this test is important for individuals potentially exposed to ticks or experiencing related symptoms.

This test measures the levels of IgG and IgM antibodies in your blood. IgM antibodies typically indicate a recent infection, while IgG antibodies suggest a past infection or an ongoing immune response. Healthcare providers use these results to determine if Babesia microti is present in the body.

Consider this test if you have recently been bitten by a tick, especially in areas known for tick-borne diseases, or if you are experiencing symptoms like fever, chills, sweats, headaches, or muscle aches. Individuals with weakened immune systems are also at higher risk and may benefit from testing.

Early detection of Babesiosis through this test allows for prompt treatment and management. It can also provide peace of mind if you suspect exposure. Discuss your results with your doctor to understand their meaning and plan any necessary next steps.
03

Medical review status

Clinical review pending

A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.

Meet the DNA Labs Kenya medical team →
04

A simple process

What happens next?

You do not have to navigate the test alone. We help you move from question to next step.

1

Speak with us

We check the test and answer your questions before collection.

2

Give your sample

Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.

3

Understand your report

A counselor helps you understand the result and the next steps.

05

Choose your collection

Home collection or a lab visit

We will explain the sample, preparation, and next steps before anything is collected.

Home collection

Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.

Lab or hub visit

Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.

Ask about locations →
PreparationNo special preparation is required for this test.
Sample2 mL (0.5 mL minimum) serum collected in an SST tube.
MethodologyConfirm with the laboratory before booking.
PrivacyYour sample and report are handled confidentially. Ask the team how your information is stored and shared.
Antibody tests may not be positive in the very early stages of infection. Results must be interpreted in conjunction with clinical signs, symptoms, and exposure history. Confirm with the laboratory before booking.
06

Read your report

What common result terms mean

PositiveA finding was identified. Your clinician or counselor will explain what it means for your care.
NegativeThe specific finding tested for was not identified. It does not rule out every possible cause.
VUSA variant was found, but current evidence is not enough to classify it. Your counselor can explain follow-up.
07

Questions people ask

Frequently asked questions

Babesiosis is a disease caused by a parasite transmitted through tick bites. It can cause flu-like symptoms and, in some cases, severe illness.
IgM antibodies usually indicate a recent or current infection. IgG antibodies suggest a past infection or an ongoing immune response.
A blood sample is required for this test. A healthcare professional will draw blood from your arm.
No special preparation, such as fasting, is required for this test.
Confirm with the laboratory before booking.
Discuss your results with your healthcare provider. They will interpret the findings in the context of your health history and symptoms and recommend appropriate management.
08

Collaboration

Open for partnership with hospitals, clinics, doctors & researchers

Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.

Hospitals & clinics

Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.

Doctors & specialists

LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.

Research institutions

Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.

Students & academic projects

Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.

Explore partnerships
09

Trust & transparency

Sources, standards & how this page is maintained

Standards & references

  • ACMG/AMP technical standards for sequence variant interpretation
  • ClinGen curation and gene–disease validity frameworks where applicable
  • LOINC-coded reporting for interoperable results
  • ISO 9001:2015 quality management; ISO 15189 accreditation in progress

Page provenance

  • Last updated: September 27, 2026
  • Medical review: not yet completed
  • Written for patients & clinicians in Kenya; reviewed periodically against current guidance

Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.

Keep exploring

Related tests

View all tests →
Chat on WhatsApp